Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

• Amedeo F. Capetti ,

  * E-mail: amedeo.capetti@unimi.it

  Affiliation 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy

  ⨯
• Gaetana Sterrantino,

  Affiliation Division of Infectious Diseases, “Careggi”, Hospital, Firenze, Italy

  ⨯
• Maria Vittoria Cossu,

  Affiliation 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy

  ⨯
• GianCarlo Orofino,

  Affiliation Division of Infectious Diseases, “Amedeo di Savoia” Hospital, Torino, Italy

  ⨯
• Giorgio Barbarini,

  Affiliation 2nd Division of Infectious Diseases, “Policlinico San Matteo” Hospital, Pavia, Italy

  ⨯
• Giuseppe V. De Socio,

  Affiliation Infectious Diseases Clinic, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy

  ⨯
• Simona Di Giambenedetto,

  Affiliation 2nd Division of Infectious Diseases, “Policlinico Universitario Agostino Gemelli” Hospital, Roma, Italy

  ⨯
• Antonio Di Biagio,

  Affiliation Infectious Diseases Clinic, “San Martino” Hospital, Genova, Italy

  ⨯
• Benedetto M. Celesia,

  Affiliation Infectious Diseases Unit, University of Catania, ARNAS (Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione) Garibaldi, Catania, Italy

  ⨯
• Barbara Argenteri,

  Affiliation 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy

  ⨯
• Giuliano Rizzardini

  Affiliations 1st Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy, Whitwaterstrand University, Johannesburg, South Africa

  ⨯